To evaluate the effect of NAT1 knock-down on tumor growth in vivo, nude mice were injected subcutaneously with parental HT-29, Control 4 or shRNA 3.2 cells and tumor development monitored over 50 days (Figure 7A). Here, NAT1 is linked to neoplasm.